Your browser doesn't support javascript.
loading
A smoking cessation intervention for rural veterans tailored to individual risk factors: A multicenter randomized clinical trial.
Vander Weg, Mark W; Howren, M Bryant; Grant, Kathleen M; Prochazka, Allan V; Duffy, Sonia; Burke, Randy; Cretzmeyer, Margaret; Parker, Christopher; Thomas, Emily B K; Rizk, Marianne T; Bayer, Jennifer; Kinner, Ellen M; Clark, Jennifer M; Katz, David A.
Afiliación
  • Vander Weg MW; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, United States of America; Department of Community and Behavioral Health, University of Iowa College of Public Health, United States of America; Department of Internal Medicine, University of Iowa Carve
  • Howren MB; VA Office of Rural Health (ORH), Veterans Rural Health Resource Center-Iowa City, United States of America; Department of Behavioral Sciences and Social Medicine, Florida State University, United States of America; Florida Blue Center for Rural Health Research & Policy, United States of America.
  • Grant KM; VA Nebraska-Western Iowa Health Care System, United States of America; University of Nebraska Medical Center Department of Medicine, United States of America.
  • Prochazka AV; Primary Care, VA Eastern Colorado Health Care System, United States of America; Denver Seattle Center for Veteran-centric Value-based Research (DiSCoVVR), United States of America.
  • Duffy S; VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, United States of America; College of Nursing, Ohio State University, United States of America.
  • Burke R; Mental Health Service, G.V. (Sonny) Montgomery VA Medical Center, United States of America; Department of Psychiatry, University of Mississippi School of Medicine, United States of America.
  • Cretzmeyer M; Department of Social Work, University of Iowa, United States of America.
  • Parker C; Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy, United States of America.
  • Thomas EBK; Department of Psychological and Brain Sciences, University of Iowa, United States of America.
  • Rizk MT; VA St. Louis Health Care System, United States of America.
  • Bayer J; Department of Psychological and Brain Sciences, University of Iowa, United States of America.
  • Kinner EM; Department of Psychological and Brain Sciences, University of Iowa, United States of America.
  • Clark JM; Department of Neurology, University of Iowa, Carver College of Medicine, United States of America.
  • Katz DA; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, United States of America; Department of Internal Medicine, University of Iowa Carver College of Medicine, United States of America; Department of Epidemiology, University of Iowa College of Public Heal
J Subst Use Addict Treat ; 156: 209191, 2024 01.
Article en En | MEDLINE | ID: mdl-37866436
ABSTRACT

INTRODUCTION:

Rates of cigarette use remain elevated among those living in rural areas. Depressive symptoms, risky alcohol use, and weight concerns frequently accompany cigarette smoking and may adversely affect quitting. Whether treatment for tobacco use that simultaneously addresses these issues affects cessation outcomes is uncertain.

METHODS:

The study was a multicenter, two-group, randomized controlled trial involving mostly rural veterans who smoke (N = 358) receiving treatment at one of five Veterans Affairs Medical Centers. The study randomly assigned participants to a tailored telephone counseling intervention or referral to their state tobacco quitline. Both groups received guideline-recommended smoking cessation pharmacotherapy, selected using a shared decision-making approach. The primary outcome was self-reported seven-day point prevalence abstinence (PPA) at three and six months. The study used salivary cotinine to verify self-reported quitting at six months.

RESULTS:

Self-reported PPA was significantly greater in participants assigned to Tailored Counseling at three (OR = 1.66; 95 % CI 1.07-2.58) but not six (OR = 1.35; 95 % CI 0.85-2.15) months. Post hoc subgroup analyses examining treatment group differences based on whether participants had a positive screen for elevated depressive symptoms, risky alcohol use, and/or concerns about weight gain indicated that the cessation benefit of Tailored Counseling at three months was limited to those with ≥1 accompanying concern (OR = 2.02, 95 % CI 1.20-3.42). Biochemical verification suggested low rates of misreporting.

CONCLUSIONS:

A tailored smoking cessation intervention addressing concomitant risk factors enhanced short-term abstinence but did not significantly improve long-term quitting. Extending the duration of treatment may be necessary to sustain treatment effects.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tabaquismo / Veteranos / Cese del Hábito de Fumar Límite: Humans Idioma: En Revista: J Subst Use Addict Treat Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tabaquismo / Veteranos / Cese del Hábito de Fumar Límite: Humans Idioma: En Revista: J Subst Use Addict Treat Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos